Green Relief Joins the Canadian Medical Cannabis Industry Association
OTTAWA, April 6, 2016 – The Canadian Medical Cannabis Industry Association (CMCIA) has announced that two new members have joined the Association. Green Relief Inc., based in Flamborough, Ontario, and Supreme Pharmaceuticals Inc., with a head office in Toronto and a seven acre hybrid greenhouse in Kincardine, Ontario, are licensed to produce medical cannabis under Health Canada’s Marihuana for Medical Purposes Regulations (MMPR).
Green Relief is Canada’s first commercial aquaponics production facility, and Supreme operates the first hybridized, modular greenhouse in Canada. Both are committed to furthering the sustainability of cannabis production to protect the environment and use natural resources responsibly.
With the addition of the two new members, CMCIA now comprises 17 of the 24 companies that currently hold the 30 Health Canada licenses to cultivate and sell medical cannabis.
“We are delighted to welcome Green Relief and Supreme to the Association,” said Colette Rivet, Executive Director of CMCIA. “They will further strengthen our organization at a critical moment in the sector’s development, as we work with government to enhance Canada’s medical cannabis system and lay the groundwork for consumer legalization.”
“It’s vital that Licensed Producers work collectively through the Association, and speak with a united voice on public policy regarding medical and consumer cannabis,” said Warren Bravo, CEO of Green Relief. “There are important decisions to be made on how to expand the medical system, and how to establish legal consumer sales, in a way that protects patients and consumers, as well as public health and safety.”
“We are thrilled to be working the the CMCIA, the leading industry association. The membership provides a breadth of experience and expertise which the Association can utilize to shape public discussion about regulation, product integrity, and the sunny future of the cannabis industry,” said John Fowler, CEO of Supreme. “We look forward to taking an active role working with the Association’s membership to further the cannabis industry in Canada, protect the interests of patients. and educate the public.”
The Canadian Medical Cannabis Industry Association (CMCIA) is Canada’s leading member-driven association for Licensed Producers (LPs) of medical cannabis. The Association represent the majority of producers currently licensed under Health Canada’s Marijuana for Medical Purposes Regulations (MMPR).
CMCIA’s mission is to promote national standards and best practices by supporting the development, growth and integrity of the medical cannabis industry. The Association acts as the national voice for Canada’s LPs, and serves as a credible and trusted resource on issues related to medical cannabis industry.
The Association shares a philosophy of patient-centric care and improved public health, and is committed to product safety and quality, secure and reliable access for registered patients, and the promotion of the safe and effective use of cannabis for medical purposes. www.cmcia.ca
This article originally appeared as a press release on the Canadian Medical Cannabis Industry Association website.